Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenues
Product Revenues	$ 186,738	$ 84,518.00	$ 53,278.00
Costs and expenses
Production costs	3,573,858	2,626,353	1,193,566
Sales and marketing	709,023	297,687	799,009
Research and development	2,359,441	3,458,564	3,371,767
General and administrative	6,723,060	4,067,710	3,921,035
Total costs and expenses	13,365,382	10,450,314	9,285,377
Operating loss	(13,178,644)	(10,365,796)	(9,232,099)
Other income (expense)
Interest expense	(62,988)	(22,257)	(21,537)
Other income (expense), net	13,990	5,994	(5,011)
Total other income (expense)	(48,998)	(16,263)	(26,548)
Net loss	(13,227,642)	(10,382,059)	(9,258,647)
Other comprehensive income (loss):
Foreign currency translation gain (loss)	214,026	(360,302)	72,388
Total other comprehensive income (loss)	214,026	(360,302)	72,388
Comprehensive loss	(13,013,616)	(10,742,361)	(9,186,259)
Earnings per share
Net loss	(13,227,642)	(10,382,059)	(9,258,647)
Deemed dividend	0	(1,822,873)	0
Net loss available to common shareholders	$ (13,227,642)	$ (12,204,932)	$ (9,258,647)
Basic and diluted net loss per share attributable to common shareholders (in dollars per share)	$ (0.66)	$ (0.94)	$ (1.06)
Weighted average number of common shares -basic and diluted (in shares)	20,078,017	13,028,760	8,772,494